Shrewsbury, MA, United States of America

Jan L Chen

USPTO Granted Patents = 7 


Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 63(Granted Patents)


Location History:

  • Worcester, MA (US) (2001 - 2002)
  • Shrewsbury, MA (US) (2006 - 2011)

Company Filing History:


Years Active: 2001-2011

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Jan L. Chen in Antiallergic Drug Development**

Introduction

Jan L. Chen, based in Shrewsbury, MA, is a prominent inventor renowned for her significant contributions to pharmaceutical advancements. With a total of seven patents to her name, she is particularly recognized for her innovative work on optically active isomers of ketotifen and their therapeutically active metabolites. These innovations are poised to redefine treatment options in allergy and inflammation.

Latest Patents

Chen's latest patents focus on the development of racemic norketotifen, racemic 10-hydroxy-ketotifen, and racemic 10-hydroxy-nor-ketotifen, along with their optically active isomers. These compounds have been evidenced to exhibit antiallergic and anti-inflammatory properties while minimizing the severe dose-limiting sedative side effects commonly associated with ketotifen. This groundbreaking research addresses a critical need in the pharmaceutical industry for safer treatment alternatives.

Career Highlights

Jan L. Chen is currently associated with Bridge Pharma Inc., where she continues to advance her research. Her dedication to innovation in the field of pharmaceuticals has led her to achieve multiple patents that showcase her expertise in drug development. Her work not only highlights her skill as an inventor but also her commitment to improving patient health outcomes.

Collaborations

Throughout her career, Chen has collaborated with esteemed colleagues such as A K Gunnar Aberg and George Edward Wright. These partnerships have been instrumental in the progress of her research and the successful completion of her innovative projects, combining their expertise to enhance the development of new therapeutic agents.

Conclusion

Jan L. Chen’s work exemplifies the impact of innovative thinking and collaboration in the field of pharmaceuticals. As she continues to build upon her research and patent portfolio, her contributions promise to advance medical science, particularly in the domain of allergy and inflammatory treatment. Her journey is an inspiration for aspiring inventors and highlights the importance of pursuing new solutions to existing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…